The role of l-arginine in inclusion complexes of omeprazole with cyclodextrins

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 233-240

  Figueiras, Ana ^a,d   Sarraguça, Jorge M G ^b,c   Pais, Alberto A C C ^b   Carvalho, Rui A ^b   Veiga, J Francisco ^d  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cyclodextrins; L arginine; Molecular dynamics simulation; NMR spectroscopy; Omeprazole

Indexed keywords

ARGININE; BETA CYCLODEXTRIN; CYCLODEXTRIN; METHYL BETA CYCLODEXTRIN; OMEPRAZOLE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ARGININE; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR DYNAMICS SIMULATION; OMEPRAZOLE; SOLUBILITY; SOLUTIONS;

EID: 77950916681     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9375-2     Document Type: Article

References (44)

1. K Karljikovic-Rajic D Novovic V Marinkovic D Agbaba 2003 First-order UV-derivative spectrophometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities J Pharm and Bio Anal 32 1019 1027 10.1016/S0731-7085(03)00204-8 1:CAS:528:DC%2BD3sXlvFyhurY%3D (Pubitemid 36951976)
2. T Pérez-Ruiz C Martínez-Lozano A Sanz E Bravo R Galera 2006 Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography J Pharm and Biom Anal 46 100 106 10.1016/j.jpba.2005.09.029 (Pubitemid 44278462)
3. N Markovic S Agotonovic-Kustrin B Glass CA Prestidge 2006 Physical and thermal characterisation of chiral omeprazole sodium salts J Pharm and Biom Anal 42 25 31 10.1016/j.jpba.2005.12.039 1:CAS:528:DC%2BD28Xosl2mtbg%3D (Pubitemid 44294738)
4. Min DS, Um KA, Kim YS, Park PW. Method for preparing enteric-coated oral drugs containing acid-unstable compounds., U.S. Patent, 1995.
5. F Salama N El-Abasawy SA Abdel-Razeq MMF Ismail MM Fouad 2003 Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates J Pharm and Biom Anal 33 411 421 10.1016/S0731-7085(03) 00233-4 1:CAS:528:DC%2BD3sXnvVertL0%3D (Pubitemid 37206466)
6. M Shimizu T Unoa T Niioka N Yaui-Furukori T Takahata K Sugawara TT Tateishi 2006 Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes J Chromat B 832 241 248 10.1016/j.jchromb.2006.01.022 1:CAS:528:DC%2BD28XitVeiu7g%3D (Pubitemid 43339953)
7. A Stroyer JW McGinity CS Leopold 2005 Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers J Pharm Sci 95 1342 1353 10.1002/jps.20450 (Pubitemid 43874448)
8. T Nakagawa S Immel FW Lichtenthaler HJ Lindner 2000 Topography of the 1:1 β-cyclodextrin-nitromethane inclusion complex Carb Res 324 141 146 10.1016/S0008-6215(99)00285-2 1:CAS:528:DC%2BD3cXpsVSruw%3D%3D (Pubitemid 30084730)
9. Y Liu G Chen Y Chen J Lin 2005 Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability Bioorg Med Chem 13 4037 4042 10.1016/j.bmc.2005.03.051 1:CAS:528:DC%2BD2MXks1Gjsrw%3D 15911316 (Pubitemid 40725035)
10. T Loftsson ME Brewster M Másson 2004 Role of cyclodextrins in improving oral drug delivery Am J Drug Deliv 2 1 15 10.2165/00137696-200402040- 00006 (Pubitemid 40045491)
11. A Figueiras JMG Sarraguça RA Carvalho AACC Pais FJB Veiga 2006 Interaction of omeprazole with a methylated derivative of β-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation Pharm Res 24 377 389 10.1007/s11095-006-9161-8 17177111 (Pubitemid 46072197)
12. J Li H Xiao J Li Y Zhongb 2004 Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers Int J Pharm 278 329 342 10.1016/j.ijpharm.2004.03.026 1:CAS:528:DC%2BD2cXkslKlsr8%3D 15196638 (Pubitemid 38759506)
13. T Loftsson 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J Pharm Sci 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D 8897265 (Pubitemid 26338912)
14. C Tirapegui F Jara J Guerrero MC Rezende 2006 Host-guest interactions in cyclodextrin inclusion complexes with solvatochromic dyes J Phys Org Chem 19 786 792 10.1002/poc.1080 1:CAS:528:DC%2BD2sXjtFOls7g%3D (Pubitemid 46353689)
15. M Fermeglia M Ferrone A Lodi S Pricl 2003 Host-guest inclusion complexes between anticancer drugs and β-cyclodextrin: computational studies Carbohydr Polym 53 15 44 10.1016/S0144-8617(03)00011-0 1:CAS:528: DC%2BD3sXjsFCksbY%3D
16. I Bea C Jaime P Kollman 2002 Molecular recognition by β-cyclodextrin derivatives: molecular dynamics, free-energy perturbation and molecular mechanics/Poisson-Boltzmann surface area goals and problems Theor Chem Acc 108 286 292 1:CAS:528:DC%2BD38XoslSls7k%3D (Pubitemid 36165346)
17. J Haller U Kaatze 2009 Octylglucopyranoside and cyclodextrin in water. Self-aggregation and complex formation J Phys Chem B 113 1940 1947 10.1021/jp808733p 1:CAS:528:DC%2BD1MXhtVejs78%3D 19170546
18. M Nilsson AJM Valente G Olofsson O Söderman M Bonini 2008 Thermodynamic and kinetic characterization of host-guest association between bolaform surfactants and α- and β-cyclodextrins J Phys Chem B 112 11310 11316 10.1021/jp802963x 1:CAS:528:DC%2BD1cXpvFSmtbY%3D 18702539
19. B Sellner G Zifferer A Kornherr D Krois UH Brinker 2008 Molecular dynamics simulations of β-cyclodextrin-aziadamantane complexes in water J Phys Chem B 112 710 714 10.1021/jp075493+ 1:CAS:528:DC%2BD1cXlslym 18166034 (Pubitemid 351212505)
20. DO Thompson 1997 Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals Crit Rev Therap Drug Carr Syst 14 1 104 1:CAS:528:DyaK2sXhtlems7g%3D
21. D Duchêne D Wouessidjewe 1990 The current state of β-cyclodextrin in pharmaceutics Acta Pharm Technol 36 1 6
22. P Mura N Zerrouk MT Faucci F Maestrelli C Chemtob 2002 Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in solid state Eur J Pharm and Biopharm 54 181 191 10.1016/S0939-6411(02)00075-9 1:CAS:528:DC%2BD38XmtlKjt7g%3D (Pubitemid 34919392)
23. L Boulmedarat A Bochot S Lesieur E Fattal 2005 Evaluation of buccal methyl-β-cyclodextrin toxicity on human oral epithelial cell culture model J Pharm Sci 94 1300 1309 10.1002/jps.20350 1:CAS:528:DC%2BD2MXkvF2qtLY%3D 15858859 (Pubitemid 40904193)
24. CA Ventura I Giannone D Paolino V Pistará A Corsaro G Puglisi 2005 Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study Eur J Med Chem 40 624 631 10.1016/j.ejmech.2005.03.001 1:CAS:528:DC%2BD2MXltFWiu78%3D 15935897 (Pubitemid 40797558)
25. C Garnero M Longhi 2007 Study of ascorbic acid interaction with hydroxypropyl-β-cyclodextrin and triethanolamine, separately and in combination J Pharm and Biom Anal 45 536 545 10.1016/j.jpba.2007.07.030 1:CAS:528:DC%2BD2sXht1Grs7rJ (Pubitemid 350007944)
26. P Mura F Maestrelli M Cirri 2003 Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and amino acids Int J Pharm 260 293 302 10.1016/S0378-5173(03)00265-5 1:CAS:528:DC%2BD3sXkvFektLg%3D 12842348 (Pubitemid 36773926)
27. P Mura GP Bettinetti M Cirri F Maestrelli M Sorrenti L Catenacci 2005 Solid-state characterization and dissolution properties of naproxen-arginine- hydroxypropyl-β-cyclodextrin ternary system Eur J Pharm and Biopharm 59 99 106 10.1016/j.ejpb.2004.05.005 1:CAS:528:DC%2BD2cXhtValsrjK (Pubitemid 39573441)
28. A Ain-Ai PK Gupta 2008 Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound Int J Pharm 351 282 288 10.1016/j.ijpharm.2007.09.029 1:CAS:528:DC%2BD1cXhs1Ogs7w%3D 18036751 (Pubitemid 351186858)
29. S Manali K Poonam S Pankajkumar V Vikrant P Yogesh 2009 Effect of PVP K30 and/or l-arginine on stability constant of etoricoxib-HPCD inclusion complex: preparation and characterization of etoricoxib-HPCD binary system Drug Dev Ind Pharm 35 118 129 10.1080/03639040802220292
30. Kolbe I, Csabai K, Szente L, Szejtli J. Development of an omeprazole/arginine/betaCD formulation. 10th International Cyclodextrin Symposium. 2000. p. 337-45.
31. Klokkers K, Kutschera M, Fischer W. Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations.U.S. Patent. 1998.
32. A Figueiras RA Carvalho L Ribeiro JJ Torres-Labandeira FJB Veiga 2007 Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin Eur J Pharm and Biopharm 67 531 539 10.1016/j.ejpb.2007.03.005 1:CAS:528: DC%2BD2sXovFyrsrc%3D (Pubitemid 47211912)
33. Higuchi T, Connors A. Phase-solubility techniques. In:Wiley-Interscience, editors. In advances in analytical chemistry instrumentation. New York: 1965. p. 117-212
34. MJ Tapia HD Burrows JM García F García AACC Pais 2004 Lanthanide ion interaction with crown ether methacrylic polymer, poly (1, 4, 7, 10-tetraoxacyclododecan-2-methyl methacrylate), as seen by spectroscopy, calorimetric and theoretical studies Macromolecules 37 856 862 10.1021/ma0353888 1:CAS:528:DC%2BD2cXmtVah
35. E Lindahl B Hess D Van der Spoel 2001 A package for molecular simulation and trajectory analysis J Mol Mod 7 306 317 1:CAS:528:DC%2BD3MXnsVGjsL4%3D (Pubitemid 36153547)
36. HJC Berendsen D Van der Spoel R Van Drunen 1995 GROMACS: a message-passing parallel molecular dynamics implementation Comput Phys Commun 91 43 56 10.1016/0010-4655(95)00042-E 1:CAS:528:DyaK2MXps1Wrtr0%3D
37. GJ Kleywegt TA Jones 1998 Databases in protein crystallography Acta Crystallogr Sect D-Biol Crystallogr D54 1119 1131 10.1107/S0907444998007100 1:CAS:528:DyaK1MXitFWr (Pubitemid 29000167)
38. AW Schuettelkopf DMF Van Aalten 2004 PRODRG-a tool for high throughput crystallography of protein-ligand complexes Acta Crystallogr Sect D-Biol Crystallogr D60 1355 1363 10.1107/S0907444904011679 1:CAS:528: DC%2BD2cXlvVegtbY%3D (Pubitemid 41079731)
39. A Brändström NA Bergman I Grundevik S Johansson L Ohlson 1998 Chemical reactions of omeprazole and omeprazole analogues. II. Kinetics of the reaction of omeprazole in the presence of 2-mercaptoethanol Acta Chem Scand 43 549 568 10.3891/acta.chem.scand.43-0549
40. R Yang SG Zavala PJ Schulman 2003 Acid-base chemistry of omeprazole in aqueous solutions Anal Chim Acta 481 155 164 10.1016/S0003-2670(03)00076-X 1:CAS:528:DC%2BD3sXhvV2ntro%3D (Pubitemid 36287620)
41. MW Schmidt KK Baldridge JA Boatz ST Elbert MS Gordon JH Jensen S Koseki N Matsunaga KA Nguyen SJ Su TL Windus M Dupuis JA Montgomery 1993 General atomic and molecular electronic-structure system J Comput Chem 14 1347 1363 10.1002/jcc.540141112 1:CAS:528:DyaK2cXhsFaqtQ%3D%3D
42. U Essman L Perela ML Berkowitz T Darden H Lee LG Pedersen 1995 A smooth particle mesh Ewald method J Chem Phys 103 8577 8592 10.1063/1.470117
43. S Miyamoto PA Kollman 1992 Settle: an analytical version of the shake and rattle algorithms for rigid water models J Comput Chem 13 952 962 10.1002/jcc.540130805 1:CAS:528:DyaK38Xlslykt7o%3D
44. HJC Berendsen JPM Postma A DiNola J Haak 1984 Molecular dynamics with coupling to an external bath J Chem Phys 81 3684 3690 10.1063/1.448118 1:CAS:528:DyaL2cXmtlGksbY%3D